Short Interest in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Rises By 296.6%

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) saw a significant increase in short interest in February. As of February 27th, there was short interest totaling 359,584 shares, an increase of 296.6% from the February 12th total of 90,658 shares. Currently, 21.0% of the company’s shares are short sold. Based on an average trading volume of 313,976 shares, the days-to-cover ratio is currently 1.1 days. Based on an average trading volume of 313,976 shares, the days-to-cover ratio is currently 1.1 days. Currently, 21.0% of the company’s shares are short sold.

Defiance Daily Target 2X Long LLY ETF Stock Performance

LLYX traded down $0.15 during midday trading on Wednesday, reaching $20.73. The company had a trading volume of 137,426 shares, compared to its average volume of 428,878. The business has a 50-day moving average of $23.34 and a two-hundred day moving average of $20.58. Defiance Daily Target 2X Long LLY ETF has a 1 year low of $9.60 and a 1 year high of $28.44.

Defiance Daily Target 2X Long LLY ETF Announces Dividend

The business also recently declared an annual dividend, which was paid on Wednesday, December 31st. Investors of record on Tuesday, December 30th were given a $0.7042 dividend. The ex-dividend date was Tuesday, December 30th. This represents a yield of 273.0%.

Institutional Investors Weigh In On Defiance Daily Target 2X Long LLY ETF

An institutional investor recently bought a new position in Defiance Daily Target 2X Long LLY ETF stock. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 5,433 shares of the company’s stock, valued at approximately $138,000. Thurston Springer Miller Herd & Titak Inc. owned approximately 0.34% of Defiance Daily Target 2X Long LLY ETF at the end of the most recent reporting period.

About Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.